Get the Stockscreener App
0.00
100.00%
-1.54
After Hours:
1.55
1.55
+
Ngm Biopharmaceuticals Inc Stock (NGM) Forecast
The Ngm Biopharmaceuticals Inc (NGM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.8741, representing a + increase from the current price of $0.00. The highest analyst price target is $1.5779, and the lowest is $0.1703.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NGM Price Target
Average 5.5886
(+ Upside)
Is Ngm Biopharmaceuticals Inc (NGM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 8.22 | Buy |
| STOCH(9,6) | 26.67 | Neutral |
| STOCHRSI(14) | 10.40 | Buy |
| MACD(12,26) | -0.1157 | Sell |
| ADX(14) | 44.75 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -466.67 | Sell |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.408
Sell
|
1.2766
Sell
|
| MA20 |
1.4775
Sell
|
1.4093
Sell
|
| MA50 |
1.5167
Sell
|
1.4338
Sell
|
| MA100 |
1.2297
Sell
|
1.4295
Sell
|
| MA200 |
1.5258
Sell
|
1.9029
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NGM could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 13 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on NGM, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 8.22 indicates that NGM is oversold. This indicates that NGM price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 26.67 indicates that NGM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.4 indicates that NGM is oversold. This suggests that NGM price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 44.75 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -466.67 indicates that NGM is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term NGM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ngm Biopharmaceuticals Inc financial reports and earnings history, Ngm Biopharmaceuticals Inc (NGM) stock could reach $13.06 by 2030, $4.4659 by 2040 and $12.31 by 2050. See the projected annual prices until 2050 of the Ngm Biopharmaceuticals Inc stock below:
- Ngm Biopharmaceuticals Inc (NGM) is expected to reach an average price of $1.1694 in 2035, with a high prediction of $1.5372 and a low estimate of $1.3078. This indicates an $ rise from the last recorded price of $0.00.
- Ngm Biopharmaceuticals Inc (NGM) stock is projected to chart a bullish course in 2040, with an average price target of $3.9014, representing an $ surge from its current level. The forecast ranges from a conservative $3.9214 to a sky-high $4.4659.
- Our analysts predict Ngm Biopharmaceuticals Inc (NGM) to jump by 2045, soaring from $10.26 to an average price of $10.20, potentially reaching $10.28. While $10.26 is the low estimate, the potential upside is significant.
- Ngm Biopharmaceuticals Inc (NGM) stock is expected to climb by 2050, reaching an average of $11.39, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $12.31 and $12.62, respectively, highlighting the market's uncertainty.
Ngm Biopharmaceuticals Inc Stock (NGM) Year by Year Forecast
Ngm Biopharmaceuticals Inc Stock (NGM) Price Forecast for 2024
Our forecast for NGM stock price in 2024 now indicates an average price target of $2.9991 with a high forecast of $5.9981 and a low forecast of $0.00. The average prediction reflects an increase of + from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $0.9779 | $0.1703 | $1.5779 | + |
| July, 2024 | $0.081 | $0.0272 | $1.3862 | + |
| August, 2024 | $4.0974 | $0.0707 | $5.0157 | + |
| September, 2024 | $3.1955 | $1.7172 | $5.9703 | + |
| October, 2024 | $1.5631 | $0.5622 | $3.7338 | + |
| November, 2024 | $0.05 | $0.00655 | $1.1452 | + |
| December, 2024 | $4.7031 | $0.5217 | $5.9981 | + |
Ngm Biopharmaceuticals Inc Stock (NGM) Price Forecast for 2025
Ngm Biopharmaceuticals Inc Stock (NGM) is expected to reach an average price of $6.63 in 2025, with a high prediction of $13.04 and a low estimate of $0.2203. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $6.0845 | $4.1414 | $8.1897 | + |
| February, 2025 | $4.0926 | $3.6276 | $7.851 | + |
| March, 2025 | $6.1157 | $3.6859 | $11.17 | + |
| April, 2025 | $1.7638 | $0.3172 | $7.409 | + |
| May, 2025 | $4.2152 | $0.2203 | $5.3013 | + |
| June, 2025 | $10.93 | $5.00 | $12.22 | + |
| July, 2025 | $11.00 | $7.7831 | $13.04 | + |
| August, 2025 | $8.4128 | $7.2345 | $12.74 | + |
| September, 2025 | $8.3859 | $6.9143 | $9.131 | + |
| October, 2025 | $7.3772 | $6.5372 | $9.0124 | + |
| November, 2025 | $5.8203 | $4.7921 | $9.4138 | + |
| December, 2025 | $7.1534 | $5.6986 | $8.0569 | + |
Ngm Biopharmaceuticals Inc Stock (NGM) Price Forecast for 2026
The predicted value for Ngm Biopharmaceuticals Inc (NGM) in 2026 is set at an average of $14.94. Estimates vary from a peak of $23.29 to a trough of $6.5966, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $14.19 | $6.8767 | $14.88 | + |
| February, 2026 | $20.12 | $13.34 | $20.54 | + |
| March, 2026 | $18.01 | $15.98 | $22.68 | + |
| April, 2026 | $20.31 | $15.48 | $21.67 | + |
| May, 2026 | $21.35 | $15.72 | $23.29 | + |
| June, 2026 | $16.79 | $16.39 | $22.46 | + |
| July, 2026 | $20.18 | $15.66 | $20.80 | + |
| August, 2026 | $10.09 | $6.5966 | $21.78 | + |
| September, 2026 | $13.39 | $10.15 | $13.78 | + |
| October, 2026 | $17.67 | $11.73 | $17.77 | + |
| November, 2026 | $14.25 | $12.92 | $18.24 | + |
| December, 2026 | $13.67 | $12.83 | $19.82 | + |
Ngm Biopharmaceuticals Inc Stock (NGM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ngm Biopharmaceuticals Inc (NGM) is $9.9234, with a high forecast of $14.91 and a low forecast of $4.9383. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $12.10 | $11.72 | $14.91 | + |
| February, 2027 | $13.01 | $10.93 | $14.58 | + |
| March, 2027 | $10.50 | $10.19 | $13.29 | + |
| April, 2027 | $9.4428 | $9.0228 | $12.57 | + |
| May, 2027 | $9.2959 | $7.5919 | $9.9059 | + |
| June, 2027 | $8.729 | $7.5507 | $10.92 | + |
| July, 2027 | $9.3603 | $7.3538 | $11.09 | + |
| August, 2027 | $9.0434 | $8.9034 | $11.95 | + |
| September, 2027 | $8.3248 | $4.9383 | $9.8517 | + |
| October, 2027 | $8.3679 | $6.8629 | $9.6655 | + |
| November, 2027 | $10.67 | $7.0045 | $10.95 | + |
| December, 2027 | $12.26 | $8.7541 | $13.42 | + |
Ngm Biopharmaceuticals Inc Stock (NGM) Price Forecast for 2028
In 2028, Ngm Biopharmaceuticals Inc (NGM) is projected to reach an average price of $6.6363, with a high projection of $13.22 and a low estimate of $0.0518. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.7755 | $9.0655 | $13.22 | + |
| February, 2028 | $8.6386 | $7.6603 | $11.90 | + |
| March, 2028 | $1.14 | $0.0518 | $8.9469 | + |
| April, 2028 | $1.3631 | $0.1183 | $2.0848 | + |
| May, 2028 | $1.2462 | $1.1262 | $1.9579 | + |
| June, 2028 | $1.5176 | $0.7128 | $2.0393 | + |
| July, 2028 | $1.6407 | $1.4659 | $2.2524 | + |
| August, 2028 | $0.7421 | $0.5921 | $1.859 | + |
| September, 2028 | $0.8852 | $0.5703 | $1.2852 | + |
| October, 2028 | $1.3283 | $0.6534 | $1.9383 | + |
| November, 2028 | $0.7397 | $0.2814 | $1.3666 | + |
| December, 2028 | $0.2728 | $0.0728 | $1.3362 | + |
Ngm Biopharmaceuticals Inc Stock (NGM) Price Forecast for 2029
The 2029 price forecast for Ngm Biopharmaceuticals Inc Stock (NGM) is $7.0422 on average, with a high prediction of $14.08 and a low estimate of $0.00103. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.1759 | $0.092 | $1.2193 | + |
| February, 2029 | $0.259 | $0.00103 | $0.4507 | + |
| March, 2029 | $0.3797 | $0.0255 | $0.6322 | + |
| April, 2029 | $0.3566 | $0.4748 | $0.4631 | + |
| May, 2029 | $0.511 | $0.5108 | $0.4334 | + |
| June, 2029 | $0.2927 | $0.3397 | $0.3786 | + |
| July, 2029 | $0.00997 | $0.0402 | $0.1326 | + |
| August, 2029 | $0.9024 | $0.1893 | $0.9976 | + |
| September, 2029 | $1.4755 | $0.8107 | $1.7655 | + |
| October, 2029 | $1.3286 | $1.1138 | $1.3436 | + |
| November, 2029 | $14.00 | $1.3469 | $12.21 | + |
| December, 2029 | $14.08 | $13.81 | $14.08 | + |
Ngm Biopharmaceuticals Inc Stock (NGM) Price Forecast for 2030
Ngm Biopharmaceuticals Inc Stock (NGM) is expected to reach an average price of $9.5597 in 2030, with a high forecast of $14.15 and a low forecast of $4.9731. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.59 | $13.51 | $13.06 | + |
| February, 2030 | $12.53 | $12.87 | $12.74 | + |
| March, 2030 | $8.7486 | $9.9564 | $12.07 | + |
| April, 2030 | $12.08 | $10.48 | $10.01 | + |
| May, 2030 | $12.18 | $12.38 | $14.15 | + |
| June, 2030 | $10.36 | $12.30 | $11.76 | + |
| July, 2030 | $6.0372 | $8.2172 | $9.3269 | + |
| August, 2030 | $5.2845 | $6.331 | $5.3491 | + |
| September, 2030 | $7.8583 | $5.5679 | $6.6983 | + |
| October, 2030 | $10.27 | $5.9621 | $6.6552 | + |
| November, 2030 | $10.41 | $10.81 | $9.8185 | + |
| December, 2030 | $4.3331 | $4.9731 | $6.9928 | + |
0.66%
0.56%
Cap:
|
Volume (24h):